This editorial discusses coronary sinus interventions as an option for patients with refractory angina pectoris who are not candidates for revascularization.
Coronary sinus intervention for the treatment of refractory angina pectoris Yoav Paz1,3, Amihay Shinfeld2,31General Intensive Care Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 2Department of Cardiac Surgery, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel; 3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelWe read with great interest the article “Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization” by Dr Richard Kones.1 Dr Kones presents an excellent review in which he describes some invasive anti-anginal therapies for the treatment of those ill-fated patients who suffer from refractory angina pectoris (RAP), a type of angina pectoris that persists despite optimal medical therapy, in patients who are not candidates for revascularization.
No takes yet. Share an insight, caveat, or question.
Paz et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: